0001209191-21-026064.txt : 20210408 0001209191-21-026064.hdr.sgml : 20210408 20210408161331 ACCESSION NUMBER: 0001209191-21-026064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210407 FILED AS OF DATE: 20210408 DATE AS OF CHANGE: 20210408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alland Leila CENTRAL INDEX KEY: 0001825216 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39539 FILM NUMBER: 21815064 MAIL ADDRESS: STREET 1: C/O PMV PHARMACEUTICALS, INC. STREET 2: 8 CLARKE DRIVE, SUITE 3 CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PMV Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001699382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463218129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 642-6664 MAIL ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-07 0 0001699382 PMV Pharmaceuticals, Inc. PMVP 0001825216 Alland Leila C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512 0 1 0 0 Chief Medical Officer Common Stock 2021-04-07 4 M 0 4000 3.90 A 4000 D Common Stock 2021-04-07 4 S 0 3972 33.8572 D 28 D Common Stock 2021-04-07 4 S 0 28 34.4211 D 0 D Employee Stock Option (right to buy) 3.90 2021-04-07 4 M 0 4000 0.00 D 2030-02-04 Common Stock 4000 373850 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.33 to $34.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.37 to $34.50, inclusive. One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter. /s/ Winston Kung, by power of attorney 2021-04-08